SENSICARDIAC vs AI-CVD

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

SENSICARDIAC

by Diacoustic Medical Devices (Pty) Ltd.

AI-CVD

by HeartLung AI

AI Verdict

SENSICARDIAC is an AI-powered solution focused on real-time heart murmur detection through electronic stethoscopes, aiding in immediate diagnosis and referral decisions. In contrast, AI-CVD utilizes existing CT scans for opportunistic screening of a wider array of cardiovascular and multisystem diseases, aiming for early detection of hidden risks. While both are cardiology AI tools, SENSICARDIAC addresses acoustic diagnostics, whereas AI-CVD focuses on imaging-based risk assessment.

Choose SENSICARDIAC if…

Choose SENSICARDIAC if your primary need is real-time, AI-assisted heart murmur detection during live patient encounters or telehealth consultations. This tool is ideal for physicians seeking to quickly classify murmurs as pathological or physiological using an electronic stethoscope, thereby streamlining diagnosis and reducing unnecessary specialist referrals.

View SENSICARDIAC →

Choose AI-CVD if…

Choose AI-CVD if you aim to leverage existing CT scan data for opportunistic screening and early detection of cardiovascular and multisystem diseases. This platform is best suited for identifying hidden health risks without requiring additional imaging or patient exposure, providing quantitative insights into cardiac structures and calcification.

View AI-CVD →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	SENSICARDIAC	AI-CVD
Deployment	SensiCardiac is a software package running on a Windows PC that interfaces with compatible electronic stethoscopes. SensiCardiac Mobi runs on a mobile device (iPhone 4S or later) and interfaces with a hosted Linux server environment. The related Telesensi platform operates entirely in the browser.	Unknown
FDA Status	Cleared AI-estimated	Unknown
HIPAA	Yes AI-estimated	Unknown

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

SENSICARDIAC

SENSICARDIAC offers a guided auscultation process and real-time analysis, suggesting a more interactive and intuitive user experience at the point of care during a patient examination. Its integration with electronic stethoscopes and desktop deployment option further enhances its direct usability for clinicians.

Clinical Value

AI-CVD

AI-CVD provides opportunistic screening for a broad range of cardiovascular and multisystem diseases by leveraging existing CT scans, enabling early detection of hidden health risks without additional procedures. This approach offers a wider potential for identifying previously undiagnosed conditions and enabling proactive intervention across a larger patient population.

Pricing & Value

Tie

Both SENSICARDIAC and AI-CVD require direct contact with the vendor for pricing information, making it impossible to conduct a head-to-head comparison of their cost or assess their value proposition. Neither tool provides publicly available details on their pricing models or subscription structures.

Enterprise Readiness

SENSICARDIAC

SENSICARDIAC explicitly states 'yes' for both HIPAA compliance and the availability of a Business Associate Agreement (BAA), providing clear assurances for enterprise deployment. Additionally, its Desktop (Windows) deployment option offers more flexibility compared to AI-CVD's cloud-only approach, potentially accommodating diverse IT infrastructures.

Innovation

AI-CVD

AI-CVD's innovative approach lies in its ability to perform opportunistic, multi-system screening for cardiovascular and other diseases using *existing* CT scans, without requiring additional imaging, radiation, or workflow disruption. This paradigm shift in leveraging readily available data for proactive risk identification represents a significant advancement in population health.

Support & Docs

Tie

Neither the provided structured facts nor readily available public information offer specific details regarding the support channels, service level agreements, or documentation quality for either SENSICARDIAC or AI-CVD. Therefore, it is not possible to distinguish between the two on this dimension.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	SENSICARDIAC	AI-CVD
Primary Function	AI-powered, cloud-based heart murmur detection service that integrates with electronic stethoscopes to classify murmurs as pathological or physiological, aiding physicians in diagnosis and reducing unnecessary referrals.	FDA-cleared, AI-powered quantitative imaging platform that performs opportunistic screening for cardiovascular and multisystem diseases using existing CT scans, enabling early detection of hidden health risks.
Input Data Type	Electronic stethoscope data (e.g., 3M Littmannu00ae 3200)	Existing chest and abdominal CT scans
Key Analysis/Output	AI-powered heart murmur detection, classification of murmurs (Class I: dangerous pathological, Class III: innocent physiological), detailed cardiac reports (downloadable PDFs, visualization, S1/S2 indicators), real-time analysis.	Automated CT-derived anatomical and density-based measurements, Coronary Artery Calcium (CAC) scoring, Aortic wall, aortic valve, and mitral valve calcium analysis, Cardiac chamber volumetry, Epicardial fat volumetry, Aorta and pulmonary artery sizing.
Specialties	Cardiology, Internal Medicine, Pediatrics	Cardiology, Pulmonology, Radiology
Technology Focus	AI-powered heart murmur screening from live diagnostic quality stethoscope streaming.	AI-enabled, CT-based opportunistic screening and early disease detection.

Videos

Demos, reviews, and walkthroughs featuring SENSICARDIAC and AI-CVD.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

How do SENSICARDIAC and AI-CVD integrate into a physician's existing clinical workflow?

SENSICARDIAC is designed for real-time, point-of-care use, integrating with electronic stethoscopes to provide immediate AI-powered heart murmur detection during patient auscultation. In contrast, AI-CVD performs opportunistic screening by analyzing existing chest and abdominal CT scans in the background, without requiring additional imaging or disrupting current radiology workflows.

What clinical insights do these tools provide, and for which patient populations are they most relevant?

SENSICARDIAC classifies heart murmurs as pathological (Class I) or physiological (Class III) and generates detailed cardiac reports, making it relevant for general cardiology, internal medicine, and pediatrics during physical exams. AI-CVD offers automated CT-derived measurements such as Coronary Artery Calcium (CAC) scoring, cardiac chamber volumetry, and epicardial fat volumetry from existing scans, primarily benefiting cardiology, pulmonology, and radiology for early detection of cardiovascular and multisystem risks in a broader adult population.

What data supports the accuracy and sensitivity of each tool in identifying relevant clinical findings?

SENSICARDIAC's AI analyzes heart murmurs against a large validated database of pathological heart murmurs, with reported accuracy above 95 percent for murmur detection. AI-CVD is an FDA-cleared, AI-powered quantitative imaging platform that provides automated measurements from CT scans for opportunistic screening.

What is the expected learning curve for physicians and their staff to effectively utilize each tool?

SENSICARDIAC features a guided auscultation process and real-time analysis, suggesting a relatively straightforward integration into existing physical exam routines for physicians and staff. AI-CVD operates through automated analysis of existing CT scans, implying minimal additional workflow disruption or specific learning for physicians beyond interpreting the generated quantitative reports.

What audit-trail features are available to track the use and findings generated by each tool?

SENSICARDIAC generates detailed cardiac reports in downloadable PDF format, which can serve as an audit trail for individual patient auscultations and AI classifications. AI-CVD provides automated CT-derived anatomical and density-based measurements, which inherently create a record of the opportunistic screening findings. Both types of AI tools are expected to have audit logs that capture inputs, outputs, model versions, and user actions for compliance and accountability.

How do these tools support multi-site rollout considerations for a large hospital system?

Both SENSICARDIAC and AI-CVD are cloud-based services, which generally facilitates multi-site deployment and scalability. SENSICARDIAC's integration with electronic stethoscopes and real-time analysis supports consistent application across various clinical settings, while AI-CVD's automated processing of existing CT scans allows for centralized analysis across a network of imaging facilities.

Beyond primary cardiology, how do these tools extend their utility to other medical specialties?

SENSICARDIAC's heart murmur detection is also applicable in Internal Medicine and Pediatrics, assisting general practitioners and pediatricians in early cardiac screening. AI-CVD's opportunistic screening from CT scans extends its utility to Pulmonology and Radiology by identifying cardiovascular and multisystem risks from imaging primarily ordered for other indications, such as lung attenuation analysis and bone mineral density.